JNPMEDI Signs Strategic Business Agreement with Korea University Medical Center for Digitalization of Clinical Trials

JNPMEDI
13 Dec 2022 · 6 minutes read

JNPMED signed a strategic business agreement with Korea University Medical Center for new drug development research and medical device clinical trials using JNPMEDI's clinical trial data collection and analysis solution Maven CDMS.

MOU with Korea University Medical Center

JNPMED announced on the 13th, signed a strategic business agreement with Korea University Medical Center for new drug development research and medical device clinical trials using JNPMEDI's clinical trial data collection and analysis solution Maven CDMS.

This agreement was promoted with the aim of promoting the development of the pharmaceutical and medical device industries by establishing a strategic cooperation system between JNPMEDI and Korea University Medical Center, strengthening the competitiveness of domestic clinical trials, and digitizing them.

Tags:
JNPMEDI
MOU
KUMC

Your Partner for a Successful Journey

JNPMEDI has been putting effort on bringing disruption on healthcare industry via integrating digital technologies to clinical research & trial operations.